(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LYMPHEDUDES

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LYMPHEDUDES

ST13

US500000086007412

Class

10

Filing

86007412

Registration

4569797

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

10/03/2024

Trademark type

Word

Nice classes

10

Filing date

07/11/2013

Registration date

07/15/2014

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/03/2024

Last transaction

10/03/2024

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

03/21/2014

First use in commerce

03/21/2014

Drawing code

4

Owner type

03

Owner location

Dalton, MA

Examiner

STEEL, ALYSSA PALADINO

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

LYMPHEDIVAS LLC
LYMPHEDIVAS LLC

Representatives

Patrick J. Concannon Nutter McClennen & Fish LLP

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Medical compression sleevesgloves for medical purposes

Publications

History of USPTO decisions and trademark events.

37 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

10/03/2024

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

10/03/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/03/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/03/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

07/15/2024

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

07/15/2023

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

02/20/2020

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

02/20/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/20/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/18/2019

E815

TEAS SECTION 8 & 15 RECEIVED

12/18/2019

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/15/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/21/2016

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/21/2016

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

04/20/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

07/15/2014

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

06/12/2014

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

06/11/2014

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

06/11/2014

SUPC

STATEMENT OF USE PROCESSING COMPLETE

06/04/2014

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/23/2014

IUAF

USE AMENDMENT FILED

04/29/2014

EISU

TEAS STATEMENT OF USE RECEIVED

04/29/2014

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/18/2014

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/24/2013

PUBO

PUBLISHED FOR OPPOSITION

12/24/2013

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/04/2013

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

11/20/2013

ALIE

ASSIGNED TO LIE

11/19/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/30/2013

XAEC

EXAMINER'S AMENDMENT ENTERED

10/29/2013

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

10/29/2013

GNEA

EXAMINERS AMENDMENT E-MAILED

10/29/2013

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/29/2013

DOCK

ASSIGNED TO EXAMINER

10/24/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/19/2013

NWAP

NEW APPLICATION ENTERED

07/15/2013

Continuous trademark protection

Get notified about every new filing that threatens LYMPHEDUDES or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.